RecruitingNCT06214507
Danon Disease Natural History Study
Studying Danon disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rocket Pharmaceuticals Inc.
- Intervention
- No intervention(other)
- Enrollment
- 60 enrolled
- Eligibility
- 8 years · All sexes
- Timeline
- 2023 – 2030
Study locations (13)
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- University of California, San Diego, La Jolla, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- University of Florida College of Medicine, Gainesville, Florida, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Washington University, St Louis, Missouri, United States
- Columbia University Medical Center/New York Presbyterian, New York, New York, United States
- Texas Children's Hospital, Houston, Texas, United States
- German Heart Center Munich, München, Germany
- Sheba Medical Center, Ramat Gan, Israel
- Azienda Ospedaliero Universitaria, Florence, Italy
- Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain
- University College London - Great Ormond Street Institute of Child Health, London, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06214507 on ClinicalTrials.govOther trials for Danon disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06092034A Gene Therapy Study of RP-A501 in Male Patients With Danon DiseaseRocket Pharmaceuticals Inc.
- RECRUITINGNANCT07336394Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance TechniquesChinese Academy of Medical Sciences, Fuwai Hospital